1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Roberto Chiarle: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma Autologous hALK.CAR T cells - Relapsed Neuroblastoma, Refractory Neuroblastoma | Phase 1 / Phase 2 | Recruiting | Roberto Chiarle | 42 | 2025-01-31 | 2025-12-26 |
Neuroblastoma (1)
United States (1)